Erik Deichmann Heegaard
Net worth: - $ as of 2024-05-30
Career history of Erik Deichmann Heegaard
Former positions of Erik Deichmann Heegaard
| Companies | Position | Start | End |
|---|---|---|---|
| EVAXION BIOTECH A/S | Chief Tech/Sci/R&D Officer | 2020-12-31 | 2023-02-28 |
| NOVO NORDISK A/S | Chief Tech/Sci/R&D Officer | 2010-12-31 | 2013-12-31 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 2014-12-31 | - |
Training of Erik Deichmann Heegaard
| University of Copenhagen | Doctorate Degree |
Statistics
International
| Denmark | 4 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
